Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 301 followers
Latest posts
Last updated about 21 hours ago
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Date of authorisation: 23/03/2018, Revision: 11, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Semglee, insulin glargine, Date of...
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation: 17/11/2025, Revision: 2, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Kefdensis, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 4, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation...
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation: 01/12/2015, Revision: 27, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Nucala, mepolizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation: 27/06/2025, Revision: 2, Status: Authorised
4 days ago
Human medicines European public assessment report (EPAR): Ziihera, zanidatamab, Date of authorisation...
Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation: 25/07/2013, Revision: 29, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation...
Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 33, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 21, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of...
Human medicines European public assessment report (EPAR): Tecovirimat SIGA, tecovirimat monohydrate, Date of authorisation: 06/01/2022, Revision: 6, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Tecovirimat SIGA, tecovirimat monohydrate, Date...
Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Date of authorisation: 21/11/2014, Revision: 19, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Date of...
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan, sitagliptin hydrochloride monohydrate,metformin hydrochloride, Date of authorisation: 16/02/2022, Revision: 7, Status: Authorised
5 days ago
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Mylan...